XML 82 R40.htm IDEA: XBRL DOCUMENT v3.22.1
Share-Based Compensation (Tables)
3 Months Ended 12 Months Ended
Mar. 31, 2022
Dec. 31, 2021
Share-based Payment Arrangement [Abstract]    
Schedule of Share-based Compensation Expense
Share-based compensation expense by type of award was as follows (in thousands):
 
    
Three Months Ended
March 31,
 
    
2022
    
2021
 
Stock options
   $ 3,030      $ 757  
Restricted stock units
     696         
Restricted stock units—executive officer
     755         
  
 
 
    
 
 
 
Total share-based compensation expense
   $ 4,481      $ 757  
  
 
 
    
 
 
 
Share-based compensation expense was as follows (in thousands):
 
    
Year Ended
December 31,
 
    
2021
    
2020
 
Research and development
   $ 1,930      $ 500  
General and administrative
     4,824        551  
  
 
 
    
 
 
 
Total
   $ 6,754      $ 1,051  
  
 
 
    
 
 
 
Summary of Stock Option Activity
A summary of stock option activity for awards under the 2017 Plan and the 2022 Plan is presented below:
 
    
Options Outstanding and Exercisable
 
    
Number of
Shares
   
Weighted
Average
Exercise
Price
    
Weighted
Average
Remaining
Contractual
Life (Years)
    
Aggregate
Intrinsic
Value
(1)

(in thousands)
 
Outstanding as of January 1, 2022
     5,598,830     $ 5.36        8.9      $ 7,349  
Granted
     2,829,435       14.87        
Forfeited
     (3,504     11.38        
Exercised
     (311,172     1.35        
  
 
 
   
 
 
       
Outstanding as of March 31, 2022
     8,113,589     $ 8.83        9.1      $ 44,630  
  
 
 
   
 
 
       
Exercisable as of March 31, 2022
     1,767,303     $ 4.83        8.1      $ 16,304  
  
 
 
   
 
 
       
 
(1)
The aggregate intrinsic value is calculated as the difference between the exercise price of the underlying options and the estimated fair value of the common stock for the options that were in the money as of March 31, 2022.
A summary of stock option activity for awards under the 2017 Plan is presented below:
 
    
Options Outstanding and Exercisable
 
    
Number of
Shares
   
Weighted
Average
Exercise
Price
    
Weighted
Average
Remaining
Contractual
Life (Years)
    
Aggregate
Intrinsic
Value
(1)

(in thousands)
 
Outstanding as of January 1, 2021
     1,952,145     $ 2.66        8.6      $ 8,143  
Granted
     4,145,794       6.31        
Forfeited
     (288,557     3.40        
Exercised
     (210,552     2.10        
  
 
 
   
 
 
       
Outstanding as of December 31, 2021
     5,598,830     $ 5.36        8.9      $ 7,349  
  
 
 
   
 
 
       
Exercisable as of December 31, 2021
     1,696,109     $ 3.72        8.0      $ 5,011  
  
 
 
   
 
 
       
 
(1)
The aggregate intrinsic value is calculated as the difference between the exercise price of the underlying options and the estimated fair value of the common stock for the options that were in the money as of December 31, 2021.
Summary of Restricted Stock Units Activity
A summary of RSU activity for awards under the 2022 Plan is presented below:
 
    
Number of
Shares
    
Weighted Average Grate
Date Fair Value
 
Outstanding as of January 1, 2022
          $  
Granted
     703,329        15.00  
Vested
             
Forfeited
     (666      15.00  
  
 
 
    
 
 
 
Outstanding as of March 31, 2022
     702,663      $ 15.00  
  
 
 
    
 
 
 
 
Schedule of Black-Scholes option pricing model for stock options granted  
The assumptions used in the Black-Scholes option pricing model for stock options granted were as follows:
 
    
2021
    
2020
 
Expected term
     6.3—7 years        7 years  
Expected volatility
     90%—110%        95%—100%  
Risk free interest rate
     0.83%—1.52%        0.42%—1.42%  
Expected dividend yield
     —%        —%  
Schedule of the Monte Carlos simulation models to determine the grant date fair value of the RSU Award   The assumptions used in the
Monte Carlo
s simulation models to determine the grant date fair value of the RSU Award for each of the three performance condition scenarios were as follows:
 
    
Change in Control
    
IPO
    
Change in Control
Following an IPO
 
Date of grant
     June 9, 2021        December 7, 2021        December 7, 2021  
Time to liquidity event (years)
     1.56—3.06        10.00        1.33  
Equity volatility
     100%—110%        70%        65%  
Risk-free interest rate
     0.11%—0.31%        1.47%        0.44%  
Discount for lack of marketability
     26%—32%        5%        5%  
Fair value of the RSU award (in thousands)
   $ 1,580      $ 10,300      $ 150